|
Beryl Drugs Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
17.60 Cr.
|
P/BV
|
2.19
|
Book Value (Rs.)
|
15.86
|
|
52 Week High/Low (Rs.)
|
45/12
|
FV/ML
|
10/1
|
P/E(X)
|
22.98
|
|
Bookclosure
|
21/09/2023
|
EPS (Rs.)
|
1.51
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | PR |
| FaceValue | 10.00 | 10.00 |
| | | |
| PER SHARE RATIOS | | |
| | | |
| Basic EPS (Rs.) | 1.96 | 0.00 |
| Diluted EPS (Rs.) | 1.96 | 0.00 |
| | | |
| PROFITABILITY RATIOS | | |
| | | |
| PBDIT Margin (%) | 10.56 | 1.89 |
| PBIT Margin (%) | 8.50 | -1.38 |
| PBT Margin (%) | 7.67 | -3.12 |
| Net Profit Margin (%) | 6.21 | -3.59 |
| NP After MI And SOA Margin (%) | 6.21 | -3.59 |
| | | |
| COVERAGE RATIOS | | |
| | | |
| Interest Coverage Ratio (%) | 10.28 | -0.79 |
| Interest Coverage Ratio (Post Tax) (%) | 8.50 | -1.06 |